Wright Medical Group NV

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. -0.27%335.151.0%$574.26m
MDTMedtronic Plc -0.29%113.530.6%$544.57m
BDXBecton, Dickinson & Co. 0.36%254.371.1%$537.59m
ISRGIntuitive Surgical, Inc. -1.13%611.292.4%$453.44m
ABTAbbott Laboratories -0.59%87.940.8%$394.90m
EWEdwards Lifesciences Corp. -0.95%231.681.2%$366.94m
DHRDanaher Corp. -0.02%160.230.7%$357.09m
BSXBoston Scientific Corp. -0.24%42.401.1%$315.75m
SYKStryker Corp. -0.17%224.101.3%$299.16m
DXCMDexCom, Inc. -3.34%292.428.2%$271.70m
ALGNAlign Technology, Inc. -3.71%262.386.4%$231.30m
BAXBaxter International, Inc. -0.17%92.901.8%$192.20m
ZBHZimmer Biomet Holdings, Inc. -0.70%157.281.7%$166.69m
TNDMTandem Diabetes Care, Inc. -2.10%88.053.9%$151.16m
ABMDABIOMED, Inc. -0.15%167.833.3%$136.89m

Company Profile

Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.